CT灌注未改变急性缺血性卒中血管内治疗患者的再灌注效应:ESCAPE-NA1试验
基于ESCAPE-NA1试验数据,410/1105例患者有CTP病灶体积和再灌注状态。CTP病灶体积在无近完全再灌注患者中总体更大,且CBF<34%、CBV<34%、CBV<38%、CBV<42%病灶体积增大与90天临床结局更差相关。CTP核心病灶体积未改变近完全再灌注对临床结局的治疗效应,CTP不能解释部分近完全再灌注患者临床结局差的原因。
要点
- CTP核心病灶体积未改变近完全再灌注对90天临床结局的治疗效应。
- CBF<34%、CBV<34%、CBV<38%、CBV<42%病灶体积增大与90天临床结局更差相关。
- 近完全再灌注患者CTP病灶体积总体更小,但差异并非均有统计学意义。
核心结论
- CTP未改变近完全再灌注对临床结局的影响,因此CTP不能解释部分近完全再灌注患者临床结局差的原因。
研究设计与样本
- 研究数据来自ESCAPE-NA1试验,该试验评估Nerinetide在血管内血栓切除术治疗卒中患者中的安全性和有效性。
- 共410/1105例患者有CTP病灶体积和再灌注状态数据。
- 入院CTP使用RAPID软件处理,在标准阈值下生成相对CBF和CBV体积图。
关键影像表现/征象
- 无近完全再灌注患者CTP病灶体积总体更大,但并非均有统计学意义。
诊断标准与关键数值
- CBF<34%、CBV<34%、CBV<38%、CBV<42%病灶体积增大与90天序贯mRS结局更差相关。
- CTP核心病灶体积未改变近完全再灌注对临床结局的治疗效应。
临床应用与阅片要点
- CTP病灶体积可用于评估与90天临床结局的关联,但未显示可改变近完全再灌注的治疗效应。
局限性
- 仅410/1105例患者有CTP病灶体积和再灌注状态数据。
- 无近完全再灌注患者CTP病灶体积总体更大,但并非均有统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Although reperfusion is associated with improved outcomes in patients with acute ischemic stroke undergoing endovascular treatment, many patients still do poorly. We investigated whether CTP modifies the effect of near-complete reperfusion on clinical outcomes, ie, whether poor clinical outcomes despite near-complete reperfusion can be partly or fully explained by CTP findings.
MATERIALS AND METHODS: Data are from the Safety and Efficacy of Nerinetide in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1) trial. Admission CTP was processed using RAPID software, generating relative CBF and CBV volume maps at standard thresholds. CTP lesion volumes were compared in patients with-versus-without near-complete reperfusion. Associations between each CTP metric and clinical outcome (90-day mRS) were tested using multivariable logistic regression, adjusted for baseline imaging and clinical variables. Treatment-effect modification was assessed by introducing CTP lesion volume × reperfusion interaction terms in the models.
RESULTS: CTP lesion volumes and reperfusion status were available in 410/1105 patients. CTP lesion volumes were overall larger in patients without near-complete reperfusion, albeit not always statistically significant. Increased CBF <34%, CBV <34%, CBV <38%, and CBV <42% lesion volumes were associated with worse clinical outcome (ordinal mRS) at 90 days. CTP core lesion volumes did not modify the treatment effect of near-complete recanalization on clinical outcome.
CONCLUSIONS: CTP did not modify the effect of near-complete reperfusion on clinical outcomes. Thus, CTP cannot explain why some patients with near-complete reperfusion have poor clinical outcomes.
引用
- Rex NB, McDonough RV, Ospel JM, et al. CT Perfusion Does Not Modify the Effect of Reperfusion in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment in the ESCAPE-NA1 Trial. AJNR Am J Neuroradiol. 2023. PMID: 37620153. doi:10.3174/ajnr.A7954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。